Calyx announced today that it partnered with Qynapse to use AI-powered neuroimaging analysis technology for central nervous system disorders. The partnership will combine Calyx’s eClinical and regulatory solutions and services with Qynapse’s artificial intelligence (AI)-based QyScore and QyPredict platforms for customers developing medical treatments for central nervous system (CNS) disorders. “We’re delighted to add Qynapse’s […]